Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Woebot Health Names Matt Borowiecki Chief Financial Officer
Woebot Health, a mental health ally for people and businesses, today announced that it has […]
ISA Pharmaceuticals to Present First Clinical Trial Data of ISA101b and Libtayo® in Head and Neck Cancer
ISA Pharmaceuticals, a clinical-stage biotechnology company developing immunotherapies to treat cancers and serious infectious diseases, […]
Transgene and BioInvent Report Positive Phase Ia Data on Oncolytic Virus BT-001 in Solid Tumors
Transgene, a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International […]
HuidaGene Therapeutics Appoints Alvin Luk as Chief Executive Officer
HuidaGene Therapeutics, a clinical-stage genome-editing company, today announced the appointment of gene therapy industry veteran, […]
Synthego Opens State-of-the-Art GMP Guide RNA Manufacturing Facility to Enable CRISPR Genomic Medicines
Synthego, a leading provider of genome engineering solutions, announced today the opening of its state-of-the-art […]
Endo Announces Agreement with MAIA Pharmaceuticals to Distribute Bivalirudin Injection in Ready-to-Use Vials
Endo International announced today that its subsidiary Endo Ventures has executed an agreement with MAIA […]
ElevateBio Announces $401 Million Series D Financing to Further Accelerate Growth
ElevateBio, a technology-driven company focused on powering the creation of life-transforming cell and gene therapies, […]
INOVIO Announces Orphan Drug Designation for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis
INOVIO, a biotechnology company focused on developing and commercializing DNA medicines to help treat and […]
WHO launching Polio Eradication Campaign in Pakistan using PharmaJet Precision Delivery System
PharmaJet®, a company engineering precision delivery systems that overcome the challenges of vaccine delivery, has […]
bit.bio Launches New Custom Disease Model Cells Offering, Advancing Disease Research and Drug Discovery
bit.bio, a cell coding company, has launched its new Custom ioDisease Model Cells offering. This […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more